Company / Interest Expense per Share
IONIS PHARMACEUTICALS INC Interest Expense per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.11
FY2025
5-year range
$0.06 / $0.12
FY2021-FY2025
Trend
-7.2%
vs FY2024
Sector context
#23 of 43
Health Care
What the data says
At $0.11, IONIS PHARMACEUTICALS INC's interest expense per share ranks #21 of 43 in the Health Care sector. Interest Expense per Share has fluctuated over the past 10 years, ranging from $0.06 in FY2022 to $0.37 in FY2017.
Based on SEC 10-K filings.
0.11 in FY2025 with a 5-year CAGR of -19.3%.
Increased from $0.09 to $0.11 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +23.9%
- 5-Year CAGR
- -19.3%
- 10-Year CAGR
- -
Sector benchmark
#21 of 43 in Health CareTop 47% of 43This company $0.11 Sector average $9.80
▼
-98.9% below sector average
Key checks
Key Insights
- In FY2025, interest expense per share decreased 7.2% year-over-year.
- Ranks #23 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2017.
- Lowest interest expense per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.11 | -7.2% |
| FY2024 | $0.12 | +32.1% |
| FY2023 | $0.09 | +54.9% |
| FY2022 | $0.06 | -35.1% |
| FY2021 | $0.09 | -72.2% |
| FY2020 | $0.32 | -1.6% |
| FY2019 | $0.32 | +4.5% |
| FY2018 | $0.31 | -15.6% |
| FY2017 | $0.37 | +14.1% |
| FY2016 | $0.32 | +3.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026